Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical study shows economic benefits of FFR

St Jude Medical study shows economic benefits of FFR

25th May 2011

St Jude Medical has published research showing how the use of fractional flow reserve (FFR) interventions in cardiovascular care can help to relieve the economic burden on the UK's healthcare system.

The company has funded a study which examined data from the landmark Fame trial to assess the cost-effectiveness benefits of using FFR devices such as St Jude's PressureWire to guide the treatment of multivessel coronary artery disease.

It was found that this technology could reduce treatment cost for percutaneous coronary intervention by around 600,000 pounds per patient, meaning the NHS could save more than 300,000 pounds in 2011.

This would also help to prevent more than 30 avoidable deaths and in excess of 70 heart attacks over two years.

Frank Callaghan, president of the St Jude Medical cardiovascular division, said: "With healthcare system finances under pressure everywhere, we are proud to offer a technology that relieves European healthcare systems from financial pressure and that protects and saves the lives of European patients."

Last month, the company was granted European marketing approval for the Accent MRI pacemaker system, which has been shown to be safe to use in a magnetic resonance imaging environment.ADNFCR-8000103-ID-800556685-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.